Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age

被引:16
作者
Bannink, Ellen M. N.
van Doorn, Jaap
Mulder, Paul G. H.
Hokken-Koelega, Anita C. S.
机构
[1] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat, Div Endocrinol, NL-3015 GJ Rotterdam, Netherlands
[2] Sophia Childrens Univ Hosp, Erasmus MC, Dept Epidemiol & Biostat, NL-3015 GJ Rotterdam, Netherlands
[3] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Metab & Endocrine Dis, NL-3508 AB Utrecht, Netherlands
关键词
D O I
10.1210/jc.2006-0677
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: IGF-I plays an important role in pre- and postnatal growth. Its serum levels are regulated by metabolic and genetic factors. Mean total IGF-I in short, small for gestational age (SGA) children is reduced, but within the normal range. Free/dissociable IGF-I is the bioactive form of IGF-I. Objectives: The aim of the study was to investigate changes in free IGF-I during GH treatment in short SGA children and to evaluate whether free IGF-I levels contribute to predicting first-year growth response and/or adult height. Design, Setting, and Intervention: We conducted a randomized, double- blind GH dose-response study with a GH dose of either 1 mg/m(2)center dot d (group A) or 2 mg/m(2)center dot d (group B). Free IGF-I, total IGF-I, and IGF binding protein (IGFBP)-3 were determined at baseline, after 1 and 5 yr, at stop, and 6 months after GH discontinuation. Patients: We studied 73 (46 male) short SGA children (36 group A) with a baseline mean age of 7.7 (2.2) yr and a mean GH duration of 8.2 (2.1) yr. Main Outcome Measures: Untreated SGA children had a mean free IGF-I SD score (SDS) of -0.2 (1.2), not related to total IGF-I. During GH therapy, free IGF-I significantly increased to 1.6 (0.7) SDS, as did total IGF-I and IGFBP-3 [2.0 (0.8) and 1.3 (0.9), respectively]. Multiple regression analysis showed that baseline free IGF-I and IGFBP-3 were negatively correlated with adult height SDS, whereas baseline bone age delay, target height SDS, baseline height SDS, and GH dose were positively correlated. Free IGF-I was also negatively correlated with first-year growth response. Conclusions: Circulating baseline free IGF-I and IGFBP-3 were better predictors for adult height in GH- treated SGA children than total IGF- I, or total IGF-I to IGFBP-3 ratio. This suggests a possible role for free IGF-I measurement in predicting the effect of GH therapy in short SGA children.
引用
收藏
页码:2992 / 3000
页数:9
相关论文
共 42 条
[1]   NATURAL GROWTH IN CHILDREN BORN SMALL-FOR-GESTATIONAL-AGE WITH AND WITHOUT CATCH-UP GROWTH [J].
ALBERTSSONWIKLAND, K ;
KARLBERG, J .
ACTA PAEDIATRICA, 1994, 83 :64-71
[2]  
[Anonymous], [No title captured]
[3]   Polymorphism in the IGF-I gene: Clinical relevance for short children born small for gestational age (SGA). [J].
Arends, N ;
Johnston, L ;
Hokken-Koelega, A ;
van Duijn, C ;
De Ridder, M ;
Savage, M ;
Clark, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) :2720-2724
[4]   GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial [J].
Arends, NJT ;
Boonstra, VH ;
Mulder, PGH ;
Odink, RJH ;
Stokvis-Brantsma, WH ;
Rongen-Westerlaken, C ;
Mulder, JC ;
Delemarre-Van de Waal, H ;
Reeser, HM ;
Jansen, M ;
Waelkens, JJJ ;
Hokken-Koelega, ACS .
CLINICAL ENDOCRINOLOGY, 2003, 59 (06) :779-787
[5]   Effect of short-term fasting on free/dissociable insulin-like growth factor I concentrations in normal human serum [J].
Bereket, A ;
Wilson, TA ;
Blethen, SL ;
Fan, J ;
Frost, RA ;
Gelato, MC ;
Lang, CH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) :4379-4384
[6]   SPONTANEOUS 24-HOUR GROWTH-HORMONE PROFILES IN PREPUBERTAL SMALL-FOR-GESTATIONAL-AGE CHILDREN [J].
BOGUSZEWSKI, M ;
ROSBERG, S ;
ALBERTSSONWIKLAND, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (09) :2599-2606
[7]   Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age [J].
Boguszewski, M ;
Jansson, C ;
Rosberg, S ;
AlbertssonWikland, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) :3902-3908
[8]   Puberty in growth hormone-treated children born small for gestational age (SGA) [J].
Boonstra, V ;
van Pareren, Y ;
Mulder, P ;
Hokken-Koelega, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) :5753-5758
[9]   Effect of different growth hormone dosages on the growth velocity in children born small for gestational age [J].
Bozzola, E ;
Lauriola, S ;
Messina, MF ;
Bona, G ;
Tinelli, C ;
Tatò, L .
HORMONE RESEARCH, 2004, 61 (02) :98-102
[10]   Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: Results of a randomized controlled study [J].
Carel, JC ;
Chatelain, P ;
Rochiccioli, P ;
Chaussain, JL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1587-1593